Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.
Buongiorno, Nalis here! A question for you to consider: Is it fair to let the Sacklers off the hook from facing future justice, if that is the best guarantee of compensation to victims of the opioid epidemic? Don’t worry if you’re not sure; the Supreme Court doesn’t seem to know either. Another hard question: mRNA vaccines for the seasonal flu — yes, or no? Keep reading to find out more, and send us your thoughts.
Supreme Court appears torn over Purdue case
The Supreme Court heard arguments on Monday about whether the Sackler family, the owner of Purdue Pharma, could be shielded from future civil lawsuits under the terms of their bankruptcy deal. As part of the deal, the Sacklers would pay up to $6 billion toward compensating people affected by the opioid crisis and, in exchange, would not face personal liability in the future.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect